Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 121

Similar articles for PubMed (Select 12219587)

1.
3.

ORS during the 2000-2001 influenza vaccination season.

Choudhri Y, Walop W, Squires S, Tam T, King A, Skowronski D, Warrington R, Wood J.

Can Commun Dis Rep. 2002 Sep 1;28(ACS-6):2-8. English, French. No abstract available.

4.

Oculo-respiratory syndrome following influenza vaccination: review of post-marketing surveillance through four influenza seasons in Canada.

[No authors listed]

Can Commun Dis Rep. 2005 Nov 1;31(21):217-25. English, French. No abstract available. Erratum in: Can Commun Dis Rep. 2005 Dec 15;31(24):260..

5.

Safety of revaccination of patients affected by the oculo-respiratory syndrome (ORS) following influenza vaccination.

Grenier JL, Toth E, De Serres G, Ménard S, Roussel R, Tremblay M, Landry M, Robert Y, Skowronski DM.

Can Commun Dis Rep. 2004 Jan 15;30(2):9-16. English, French. No abstract available.

6.

Oculo-respiratory syndrome: a new influenza vaccine-associated adverse event?

Skowronski DM, Strauss B, De Serres G, MacDonald D, Marion SA, Naus M, Patrick DM, Kendall P.

Clin Infect Dis. 2003 Mar 15;36(6):705-13. Epub 2003 Mar 5.

7.

Oculo-respiratory syndrome in association with the influenza vaccine: Canada, October-November 2000.

[No authors listed]

Can Commun Dis Rep. 2000 Dec 1;26(23):201-2. English, French. No abstract available.

8.

Clinical manifestations and incidence of oculo-respiratory syndrome following influenza vaccination--Quebec, 2000.

Boulianne N, De Serres G, Duval B, Shadmani R, Rochette L.

Can Commun Dis Rep. 2001 May 15;27(10):85-90. English, French. No abstract available.

9.

Oculo-respiratory syndrome after influenza vaccination: trends over four influenza seasons.

De Serres G, Toth E, Ménard S, Grenier JL, Roussel R, Tremblay M, Landry M, Robert Y, Rochette L, Skowronski DM.

Vaccine. 2005 May 25;23(28):3726-32.

PMID:
15882534
10.

Oculorespiratory syndrome after influenza immunization in children.

Skowronski DM, Bjornson G, Husain E, Metzger DL, Scheifele DW.

Pediatr Infect Dis J. 2005 Jan;24(1):63-9.

PMID:
15665712
11.

Oculo-respiratory syndrome following influenza vaccination: evidence for occurrence with more than one influenza vaccine.

De Serres G, Boulianne N, Duval B, Rochette L, Grenier JL, Roussel R, Donaldson D, Tremblay M, Toth E, Ménard S, Landry M, Robert Y.

Vaccine. 2003 Jun 2;21(19-20):2346-53.

PMID:
12744865
12.

Randomized, double-blind, placebo-controlled trial to assess the rate of recurrence of oculorespiratory syndrome following influenza vaccination among persons previously affected.

Skowronski DM, De Serres G, Scheifele D, Russell ML, Warrington R, Davies HD, Dionne M, Duval B, Kellner J, MacDonald J.

Clin Infect Dis. 2003 Oct 15;37(8):1059-66. Epub 2003 Sep 26.

13.

Skin testing to evaluate oculo-respiratory syndrome (ORS) associated with influenza vaccination during the 2000-2001 season.

Skowronski DM, De Serres G, Hebert J, Stark D, Warrington R, Macnabb J, Shadmani R, Rochette L, MacDonald D, Patrick DM, Duval B.

Vaccine. 2002 Jun 21;20(21-22):2713-9.

PMID:
12034097
14.

The clinical spectrum of the oculo-respiratory syndrome after influenza vaccination.

De Serres G, Grenier JL, Toth E, Ménard S, Roussel R, Tremblay M, Fradet MD, Landry M, Robert Y, Skowronski DM.

Vaccine. 2003 Jun 2;21(19-20):2354-61.

PMID:
12744866
15.

Ophthalmological and biological features of the oculorespiratory syndrome after influenza vaccination.

Fredette MJ, De Serres G, Malenfant M.

Clin Infect Dis. 2003 Oct 15;37(8):1136-8. Epub 2003 Sep 18.

16.

Influenza vaccine oculorespiratory syndrome incidence is reduced in HIV.

Cooper C, Thorne A; Canadian Institutes of Health Research-Canadian HIV Trials Network (CTN) Influenza Vaccine Research Group.

Vaccine. 2011 Oct 19;29(45):7876-7. doi: 10.1016/j.vaccine.2011.08.066. Epub 2011 Aug 26.

PMID:
21872629
17.

Low risk of recurrence of oculorespiratory syndrome following influenza revaccination.

Skowronski DM, Strauss B, Kendall P, Duval B, De Serres G.

CMAJ. 2002 Oct 15;167(8):853-8.

18.

Does antigen-specific cytokine response correlate with the experience of oculorespiratory syndrome after influenza vaccine?

Skowronski DM, Lu H, Warrington R, Hegele RG, De Serres G, HayGlass K, Stark D, White R, Macnabb J, Li Y, Manson HE, Brunham RC.

J Infect Dis. 2003 Feb 1;187(3):495-9. Epub 2003 Jan 24.

19.

Effectiveness of influenza vaccination of children with recurrent respiratory tract infections in reducing respiratory-related morbidity within the households.

Esposito S, Marchisio P, Cavagna R, Gironi S, Bosis S, Lambertini L, Droghetti R, Principi N.

Vaccine. 2003 Jul 4;21(23):3162-8.

PMID:
12804844
20.

Aggregate content influences the Th1/Th2 immune response to influenza vaccine: evidence from a mouse model.

Babiuk S, Skowronski DM, De Serres G, HayGlass K, Brunham RC, Babiuk L.

J Med Virol. 2004 Jan;72(1):138-42.

PMID:
14635022
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk